Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1979 Sep;64(3):775–780. doi: 10.1172/JCI109523

Mechanism of Action of Colchicine in Acute Urate Crystal-Induced Arthritis

Isaias Spilberg 1,2, Brian Mandell 1,2, Jagdish Mehta 1,2, Louis Simchowitz 1,2, David Rosenberg 1,2
PMCID: PMC372181  PMID: 468993

Abstract

Phagocytosis of urate crystals by human or rabbit neutrophils induces the synthesis and release of a glycoprotein, the crystal-induced chemotactic factor (CCF), which is chemotactically active both in vitro and in vivo. It has been proposed that CCF is a prime mediator of the acute gouty attack. Colchicine has been shown to decrease the production and release of this factor in vitro. In these studies, colchicine, at nonleukopenic doses, is shown to abrogate the acute arthritis induced by monosodium urate crystals in rabbits, but to have no effect upon the arthritis induced by the injection of the purified cell-derived chemotactic factor. Serum colchicine levels were 0.48-0.58 μM at 30 min and 0.12-0.3 μM at 90 min after intravenous injection of 0.2 mg/kg colchicine. Peripheral blood polymorphonuclear leukocytes obtained from colchicine-treated animals migrated normally towards a chemotactic stimulus but failed to produce CCF after phagocytosis of monosodium urate crystals. The dialyzed synovial fluid from rabbits injected with microcrystalline sodium urate contained chemotactic activity that was not present when animals were also given intravenous colchicine or injected intra-articularly with the chemotactic factor formyl-methionyl-leucyl-phenylalanine. Furthermore, the synovial fluid from rabbits injected with microcrystalline sodium urate significantly decreased 125I-CCF binding to neutrophils. The binding of 125I-CCF to its neutrophil receptor was not significantly reduced by the synovial fluid of colchicine-treated rabbits nor by the synovial fluid of control rabbits injected with the chemotactic factor formyl-methionyl-leucyl-phenylalanine. Colchicine (10 and 0.1 μM) was shown to have no effect upon the binding of 125I-CCF to its cell receptor.

Full text

PDF
775

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed] [Google Scholar]
  2. Caner J. E. Colchicine inhibition of chemotaxis. Arthritis Rheum. 1965 Oct;8(5):757–764. doi: 10.1002/art.1780080438. [DOI] [PubMed] [Google Scholar]
  3. Dinarello C. A., Chusid M. J., Fauci A. S., Gallin J. I., Dale D. C., Wolff S. M. Effect of prophylactic colchicine therapy on leukocyte function in patients with familial Mediterranean fever. Arthritis Rheum. 1976 May-Jun;19(3):618–622. doi: 10.1002/art.1780190315. [DOI] [PubMed] [Google Scholar]
  4. MALAWISTA S. E., SEEGMILLER J. E. THE EFFECT OF PRETREATMENT WITH COLCHICINE ON THE INFLAMMATORY RESPONSE TO MICROCRYSTALLINE URATE: A MODEL FOR GOUTY INFLAMMATION. Ann Intern Med. 1965 Apr;62:648–657. doi: 10.7326/0003-4819-62-4-648. [DOI] [PubMed] [Google Scholar]
  5. Malawista S. E., Andriole V. T. Colchicine: anti-inflammatory effect of low doses in a sensitive bacterial system. J Lab Clin Med. 1968 Dec;72(6):933–942. [PubMed] [Google Scholar]
  6. Malawista S. E. The action of colchicine in acute gouty arthritis. Arthritis Rheum. 1975 Nov-Dec;18(6 Suppl):835–846. doi: 10.1002/art.1780180729. [DOI] [PubMed] [Google Scholar]
  7. Malech H. L., Root R. K., Gallin J. I. Structural analysis of human neutrophil migration. Centriole, microtubule, and microfilament orientation and function during chemotaxis. J Cell Biol. 1977 Dec;75(3):666–693. doi: 10.1083/jcb.75.3.666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Mandell B. F., Stahl P. D. Demonstration of microtubule independent protein secretion from rat liver. Experientia. 1977 Nov 15;33(11):1464–1465. doi: 10.1007/BF01918810. [DOI] [PubMed] [Google Scholar]
  9. Marks A., Mahony J. B., Brown I. R. Colchicine inhibits the accumulation of messenger RNA for a brain-specific protein in rat glial cells. Biochem Biophys Res Commun. 1978 Jun 29;82(4):1306–1313. doi: 10.1016/0006-291x(78)90330-3. [DOI] [PubMed] [Google Scholar]
  10. Phelps P., McCarty D. J., Jr Crystal-induced arthritis. Postgrad Med. 1969 Jan;45(1):87–93. doi: 10.1080/00325481.1969.11696985. [DOI] [PubMed] [Google Scholar]
  11. Phelps P. Polymorphonuclear leukocyte motility in vitro. 3. Possible release of a chemotactic substance after phagocytosis of urate crystals by polymorphonuclear leukocytes. Arthritis Rheum. 1969 Jun;12(3):197–204. doi: 10.1002/art.1780120306. [DOI] [PubMed] [Google Scholar]
  12. Spilberg I. Current concepts of the mechanism of acute inflammation in gouty arthritis. Arthritis Rheum. 1975 Mar-Apr;18(2):129–134. doi: 10.1002/art.1780180208. [DOI] [PubMed] [Google Scholar]
  13. Spilberg I., Gallacher A., Mandell B. Calcium pyrophosphate dihydrate (CPPD) crystal-induced chemotactic factor: subcellular localization, role of protein synthesis and phagocytosis. J Lab Clin Med. 1977 Apr;89(4):817–822. [PubMed] [Google Scholar]
  14. Spilberg I., Gallacher A., Mendell B. Studies on crystal-induced chemotactic factor. II. Role of phagocytosis. J Lab Clin Med. 1975 Apr;85(4):631–636. [PubMed] [Google Scholar]
  15. Spilberg I., Mandell B., Wochner R. D. Studies on crystal-induced chemotactic factor. I. Requirement for protein synthesis and neutral protease activity. J Lab Clin Med. 1974 Jan;83(1):56–63. [PubMed] [Google Scholar]
  16. Spilberg I., Mehta J. Demonstration of a specific neutrophil receptor for a cell-derived chemotactic factor. J Clin Invest. 1979 Jan;63(1):85–88. doi: 10.1172/JCI109282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Spilberg I., Osterland C. K. Anti-inflammatory effect of the trypsin-kallikrein inhibitor in acute arthritis induced by urate crystals in rabbits. J Lab Clin Med. 1970 Sep;76(3):472–479. [PubMed] [Google Scholar]
  18. Spilberg I., Rosenberg D., Mandell B. Induction of arthritis by purified cell-derived chemotactic factor: role of chemotaxis and vascular permeability. J Clin Invest. 1977 Mar;59(3):582–585. doi: 10.1172/JCI108674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Spilberg I. Urate crystal arthritis in animals lacking Hageman factor. Arthritis Rheum. 1974 Mar-Apr;17(2):143–148. doi: 10.1002/art.1780170206. [DOI] [PubMed] [Google Scholar]
  20. Spilbert I., Gallacher A., Mehta J. M., Mandell B. Urate crystal-induced chemotactic factor: isolation and partial characterization. J Clin Invest. 1976 Oct;58(4):815–819. doi: 10.1172/JCI108533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Tse R. L., Phelps P. Polymorphonuclear leukocyte motility in vitro. V. Release of chemotactic activity following phagocytosis of calcium pyrophosphate crystals, diamond dust, and urate crystals. J Lab Clin Med. 1970 Sep;76(3):403–415. [PubMed] [Google Scholar]
  22. Tsung P. K., Kegeles S. W., Becker E. L. The evidence for the existence of chymotrypsin-like esterase activity in the plasma membranes of rabbit neutrophils and the specific chemotactic peptide binding activity of the subcellular fractions. Biochim Biophys Acta. 1978 Jun 15;541(2):150–160. doi: 10.1016/0304-4165(78)90388-4. [DOI] [PubMed] [Google Scholar]
  23. Wallace S. I., Bernstein D., Diamond H. Diagnostic value of the colchicine therapeutic trial. JAMA. 1967 Feb 20;199(8):525–528. [PubMed] [Google Scholar]
  24. Wallace S. L. Colchicine. Semin Arthritis Rheum. 1974 Summer;3(4):369–381. doi: 10.1016/0049-0172(74)90006-7. [DOI] [PubMed] [Google Scholar]
  25. Wright D. G., Malawista S. E. Mobilization and extracellular release of granular enzymes from human leukocytes during phagocytosis: inhibition by colchicine and cortisol but not by salicylate. Arthritis Rheum. 1973 Nov-Dec;16(6):749–758. doi: 10.1002/art.1780160608. [DOI] [PubMed] [Google Scholar]
  26. Zemer D., Revach M., Pras M., Modan B., Schor S., Sohar E., Gafni J. A controlled trial of colchicine in preventing attacks of familial mediterranean fever. N Engl J Med. 1974 Oct 31;291(18):932–934. doi: 10.1056/NEJM197410312911803. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES